RENITEC Tablet Ref.[51094] Active ingredients: Enalapril

Source: Pharmaceutical Benefits Scheme (AU)  Revision Year: 2021  Publisher: Organon Pharma Pty Ltd, Building A, 26 Talavera Road, Macquarie Park NSW 2113

Product name and form

Enalapril maleate.

Pharmaceutical Form

RENITEC M (enalapril maleate) 5mg, white, barrel-shaped biconvex compressed tablet, scored on one side and engraved ‘RENITEC’ on the other.

RENITEC (enalapril maleate) 10mg, rust-red, barrel-shaped biconvex compressed tablet, scored on one side and engraved ‘RENITEC’ on the other.

RENITEC 20 (enalapril maleate) 20mg, peach barrel-shaped biconvex compressed tablet engraved ‘MSD714’ on one side.

Qualitative and quantitative composition

Enalapril maleate is a white to off-white crystalline powder. It is sparingly soluble in water, soluble in ethanol, and freely soluble in methanol and dimethylformamide.

RENITEC tablets contain 5 mg, 10 mg or 20 mg enalapril maleate.

List of excipients with known effect: sugars as lactose.

For the full list of excipients, see Section 6.1 List of Excipients.

Active Ingredient Description
Enalapril

Enalapril is hydrolysed via hepatic CES 1 to the active metabolite enalaprilat, which acts as an ACE inhibitor. ACE is a peptidyl dipeptidase which catalyses the conversion of angiotensin I to the vasoconstrictor substance angiotensin II and hence inhibition of ACE results in decreased plasma angiotensin II. This also leads to increased plasma renin activity and decreased aldosterone secretion. The mechanism of action of enalapril is therefore primarily via the suppression of the RAAS. However, ACE is identical to kininase II, and so enalapril may also exert its effects by blocking the degradation of bradykinin, a potent vasodepressor peptide.

List of Excipients

Sodium bicarbonate
Lactose monohydrate
Maize starch
Pregelatinised maize starch
Magnesium stearate
Iron oxide red (10mg and 20mg RENITEC tablets only)
Iron oxide yellow (20mg RENITEC tablets only)

Pack sizes and marketing

Supplied in blister packs of 30 tablets.

Marketing authorization holder

Organon Pharma Pty Ltd, Building A, 26 Talavera Road, Macquarie Park NSW 2113

Marketing authorization dates and numbers

Date of first approval: 10 May 1996

Drugs

Drug Countries
RENITEC Austria, Australia, Brazil, Ecuador, Estonia, Spain, Finland, France, Netherlands, New Zealand, Romania, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.